Prosus Ventures — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
Bilt is a rewards program that lets renters and homeowners earn points on rent and mortgage payments, either through partner properties' resident portals or its BillPay product for any home.
ConsumerFintechPropTech
Ankur Jain(Founder)in
Co-investorsLeft Lane CapitalCamber CreekEldridgeGeneral Catalyst
BILT provides "Intelligent Instructions" — 3D interactive, voice- and animation-guided digital workflows for product assembly, installation, maintenance, and repair.
AI & Machine LearningEnterprise SoftwareSaaSGrapevine, US
Co-investorsSilverton PartnersCamber CreekEldridgeGeneral CatalystLeft Lane Capital
Bilt operates a rewards program that allows renters and homeowners to earn points on rent and mortgage payments, which can be redeemed for travel, everyday purchases, or neighborhood benefits at partner merchants.
B2B MarketplacesConsumerFintechNew York, US
Ankur Jain(Founder & CEO)inDavid Wyler(Founder)Alexander Lockwood Klokus(Executive Officer, Director)
BoardKenneth Chenault(Director)Harley Miller(Director)inAlex Fiance(Director)
Co-investorsAcrew CapitalCamber CreekDERIVE VENTURESElizabeth Street VenturesFifth WallFin Capital+8 more
Incognia provides device intelligence and identity verification solutions combining device recognition, location analysis, and tamper detection for fraud prevention and user verification.
AI & Machine LearningCybersecurityData & InfrastructureFintech
André F.(Founder)inAlan Gomes(Founder)in
Co-investorsBessemer Venture PartnersPoint72 VenturesValor Capital GroupFJ LabsPoint72
Kismet is a platform that matches people using Australia's National Disability Insurance Scheme (NDIS) with suitable service providers and offers tools for NDIS budgeting, financial management, and plan navigation.
Digital HealthHealthtechMarketplaces
Co-investorsAirTree VenturesCrane Venture PartnersDarcy NauntonFlying Fox Ventures
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactHumboldt+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.